The pharmaceutical world is observing a major shift in glucose therapy with the emergence of GLP-1 skin applications. These patches offer a potentially more user-friendly alternative to subcutaneous administrations of GLP-1 drugs, reducing the requirement of daily needle pricks. The innovation re